Citations

Clear

2960 citation(s) found for "Kim, P".

The canine homolog of human receptive speech area responds selectively to social reinforcement
Miller, Kai J. , Lampert, F. , Kim, Inyong , Ince, Nuri F. , Hermes, Dora, Lampert, Frederik, Mívalt, Filip , Kim, Jiwon W. , Křemen, Václav , Baker, Matthew , Boom, Max van den , Hermes, Dora , Coenen, Volker Arnd , Schalk, Gerwin , Brunner, Peter , Worrell, Gregory A.

Mayo Clinic

No container title available | October 16, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-5183241/v1 Get It

Abstract Studying mammalian brain function aids our understanding of human brain evolution. We implanted a beagle with a prototype human neuromodulation platform that measures activity from the brain surface. One year later, a set of simple sensory tasks was performed, finding visual and somatosensory representation in the canine homologs of the expected areas in humans. Surprisingly, the canine anterior ectosylvian gyrus, which is anatomically homologous to human receptive speech areas, was selectively active during independent social reinforcement tasks. This suggests that human speech understanding may have evolved from more general mammalian brain structures that are specialized for social reinforcement.
The Brief Case: Human leptospirosis acquired in Minnesota and diagnosed using 16S ribosomal RNA gene PCR/next-generation sequencing of blood
Kim, Myeongji , Enzler, Mark J., Pritt, Bobbi S. , Kumlien, Aaron C., Theel, Elitza S. , Norgan, Andrew P. , Paisie, Taylor K. , Patel, Robin , Patel, Robin , Pritt, Bobbi S , Norgan, Andrew P , Wolf, Matthew J.

Mayo Clinic

Journal of Clinical Microbiology | October 16, 2024 | Volume: 62 | Issue: 10 | Pages: No page available

10.1128/jcm.00572-24 Get It

Defining Echocardiographic Degrees of Right Heart Size and Function in Pulmonary Vascular Disease From the PVDOMICS Study
Mukherjee, Monica , Mathai, Stephen C. , Jellis, Christine , Freed, Benjamin H. , Yanek, Lisa R. , Agoglia, Hannah , Chiu, Caitlin , Jani, Vivek , Simpson, Catherine E. , Park, Margaret , Beck, Gerald J. , Hill, Nicholas S. , Erzurum, Serpil C. , Thomas, James D. , Kwon, Deborah , Kim, Jiwon , Group, the PVDOMICS Study, Mathai, Stephen C , Simpson, Catherine E , Freed, Benjamin H , Mukherjee, Monica , Brittain, Evan L , Tang, W.H. Wilson , Hemnes, Anna R. , Rosenzweig, Erika B. , Rischard, Franz , Frantz, Robert P. , Hassoun, Paul M. , Leopold, Jane A. , Horn, Evelyn M. , Group, the PVDOMICS Study

Mayo Clinic

Circulation: Cardiovascular Imaging | October 15, 2024 | Volume: 17 | Issue: 10 | Pages: No page available

10.1161/circimaging.124.017074 | PMID 39691460 Get It

BACKGROUND: Defining qualitative grades of echocardiographic metrics of right heart chamber size and function is critical for screening, clinical assessment, and measurement of therapeutic response in individuals with pulmonary vascular disease (PVD). In a population enriched for PVD, we sought to establish qualitative grades and prognostic value of right heart chamber size and function. METHODS: We investigated 1053 study participants in PVDOMICS (Redefining Pulmonary Hypertension Through the PVD Phenomics Program) to determine clinical and echocardiographic differences associated with increasing pulmonary vascular resistance severity. Right heart chamber size and function were qualitatively assessed using a percentile-based approach above the median values to create a clinical grading system for right heart adaptation. The relationship between echocardiographic categories and all-cause mortality was examined using survival analyses adjusted for potential confounders. RESULTS: A stepwise increase in adverse right heart remodeling was observed with a concomitant decrease in functional parameters by pulmonary vascular resistance strata ( P <0.001 for all). Mild, moderate, and severe categories of right heart chamber size and dysfunction were defined using a percentile-based approach across the spectrum of PVD. During a median follow-up of 2.07 years (interquartile range, 1.23–3.01 years), 130 participants died (11.4%). Progressive pulmonary vascular resistance increase and 2DE evidence of right heart dysfunction inclusive of fractional area change, and right ventricular global longitudinal strain were independently associated with increased all-cause mortality risk in multivariate analysis adjusted for age, disease duration, and male sex. CONCLUSIONS: In this well-characterized sample of adults with diverse etiologies and varying PVD severity, we define categories of abnormal right heart chamber size and function. Further, we demonstrate a stepwise relationship between these categories of abnormal morphology and function and all-cause mortality. Defining grades of right ventricular dysfunction in individuals with known PVD has important clinical implications for monitoring disease progression and response to therapies.
Incidence, Mechanisms, and Clinical Characteristics of Traumatic Iritis: A Population-Based Analysis
Wang, Kenny Y. , Kim, B. Michelle, Xu, Timothy T. , Hodge, David O. , Smith, Wendy M. , Reynolds, Margaret

Mayo Clinic

Ocular Immunology and Inflammation | October 15, 2024 | Volume: 33 | Issue: 3 | Pages: 378-384

10.1080/09273948.2024.2413899 | PMID 39405056 Get It

Predicting Futile Recanalization After Endovascular Thrombectomy for Patients With Stroke With Large Cores: The SNAP Score
Matsukawa, Hidetoshi , Uchida, Kazutaka , Maier, Ilko , Jabbour, Pascal , Kim, Joon‐Tae , Wolfe, Stacey Q , Rai, Ansaar , Starke, Robert M. , Psychogios, Marios‐Nikos, Samaniego, Edgar A. , Grossberg, Jonathan A , Tanweer, Omar , Mascitelli, Justin, Polifka, Adam , Crosa, Roberto , Park, Min S. , Brinjikji, Waleed , Williamson, Richard , Navía, Pedro , Kan, Peter , Chowdhry, Shakeel , Ezzeldin, Mohamad , Spiotta, Alejandro M , Collaborators, for the Stroke Thrombectomy and Aneurysm Registry (STAR), Crosa, Roberto , Samaniego, Edgar A , Wolfe, Stacey Quintero , Matsukawa, Hidetoshi , Navia, Pedro , Chen, Huanwen , Elawady, Sameh Samir , Cunningham, Conor M. , Sowlat, Mohammad‐Mahdi , Jabbour, Pascal , Arthur, Adam Stephen , Yoshimura, Shinichi , Cuellar, Hugo, Alawieh, Ali , Romano, Daniele G., Mascitelli, Justin R , Fragata, Isabel , Osbun, Joshua W , Matouk, Charles , Levitt, Michael R. , Moss, Mark, Leacy, Reade De , Collaborators, for the Stroke Thrombectomy and Aneurysm Registry (STAR)

Mayo Clinic

Neurosurgery | October 11, 2024 | Volume: 96 | Issue: 5 | Pages: 1080-1088

10.1227/neu.0000000000003220 | PMID 39471074 Get It

BACKGROUND AND OBJECTIVES: We aimed to develop and validate a prediction score for futile recanalization (FR) for large vessel occlusion (LVO) presenting low Alberta Stroke Program Early Computed Tomography Score (ASPECTS) for patients who underwent endovascular thrombectomy (EVT). METHODS: Patients with anterior circulation LVO with low ASPECTS (<6) who underwent successful EVT (modified treatment in cerebral ischemia score ≥2b) from Stroke Thrombectomy and Aneurysm Registry were retrospectively analyzed. FR was defined as 90-day modified Rankin Scale (mRS) scores ≥4 despite successful EVT. Multivariable logistic regression was used to identify independent predictors of FR, and they were used to create a clinical score. The performance of the score was assessed by receiver operating characteristic curve analyses. RESULTS: Of 219 patients, 170 and 49 patients were randomly assigned to the training and validation cohort, respectively. Independent predictors of FR identified in the training cohort were used to construct the SNAP score: site of occlusion (middle cerebral artery = 0, internal carotid artery = 1), National Institutes of Health Stroke Scale score at admission (≤10 = 0, 10 to 19 = 1, ≥20 = 2), age (<75 = 0, ≥75 = 2), and prestroke mRS score (0-3). Receiver operating characteristic curve analyses of the SNAP score in the training and validation cohorts showed areas under the curve of 0.79 (95% CI 0.72-0.86) and 0.79 (95% CI 0.65-0.92) for predicting FR, respectively. A SNAP score ≥5 had a positive predictive value of 92.1% [95% CI 78.8%-97.3%] for FR. CONCLUSION: The SNAP score may be useful in predicting FR after EVT in low-ASPECTS patients with LVO. It can provide patients, family members, and physicians with reliable outcome expectations among patients with acute ischemic stroke with large infarcts.
Microsurgical Treatment of Intracranial Dural Arteriovenous Fistulas: A Collaborative Investigation From the Multicenter Consortium for Dural Arteriovenous Fistula Outcomes Research
Raygor, Kunal P. , Abdelsalam, Ahmed , Raper, Daniel , Guniganti, Ridhima , Durnford, Andrew , Brinjikji, Waleed , Abecassis, Isaac Josh, Polifka, Adam , Samaniego, Edgar A. , Kwasnicki, Amanda , Potgieser, Adriaan R. E., Tada, Yoshiteru , Kansagra, Akash P. , Satomi, Junichiro, Eatz, Tiffany , Peterson, Eric C. , Starke, Robert M., Dijk, J. Marc C. van , Hayakawa, M. , Gross, Bradley A. , Fox, W. Christopher, Kim, Louis J. , Sheehan, Jason , Bulters, Diederik , Zipfel, Gregory J. , Abla, Adib A. , Alaraj, Ali , Eatz, Tiffany , Alaraj, Ali , Samaniego, Edgar A , van DijK, J Marc C , Abla, Adib , Bulters, Diederik O , Tonetti, Daniel A. , Giordan, Enrico , Chen, Ching‐Jen , Levitt, Michael R. , Derdeyn, Colin P. , Chen, Stephanie , Peterson, Eric C., Amin-Hanjani, Sepideh , Gross, Bradley , Fox, W Christopher , Kim, Louis J. , Lanzino, Giuseppe , Du, Rose , Lai, Pui Man Rosalind

Mayo Clinic

Neurosurgery | October 8, 2024 | Volume: 96 | Issue: 5 | Pages: 1023-1034

10.1227/neu.0000000000003204 | PMID 39471093 Get It

BACKGROUND AND OBJECTIVES: First-line therapy for most intracranial dural arteriovenous fistulas (dAVFs) is endovascular embolization, but some require microsurgical ligation due to limited endovascular accessibility, anticipated lower cure rates, or unacceptable risk profiles. We investigated the most common surgically treated dAVF locations and the approaches and outcomes of each. METHODS: The Consortium for Dural Arteriovenous Fistula Outcomes Research database was retrospectively reviewed. Patients who underwent dAVF microsurgical ligation were included. Patient demographics, angiographic information, surgical details, and postoperative outcomes were collected. The 5 most common surgically treated dAVF locations were analyzed about used surgical approaches and postoperative outcomes. Univariate analyses were performed with statistical significance set at a threshold of P < .05. RESULTS: In total, 248 patients in the Consortium for Dural Arteriovenous Fistula Outcomes Research database met inclusion criteria. The 5 most common surgically treated dAVF locations were tentorial, anterior cranial fossa (ACF), transverse-sigmoid sinus (TSS), convexity/superior sagittal sinus (SSS), and torcular. Most tentorial dAVFs were approached using a suboccipital, lateral supracerebellar infratentorial approach (39.3%); extended retrosigmoid approach (ERS) (25%); or posterior subtemporal approach (19.6%). All ACF dAVFs used a subfrontal approach; 5.3% also included an anterior interhemispheric approach. Most TSS dAVFs were ligated via ERS (31.3%) or subtemporal (31.3%) approaches. All convexity/SSS dAVFs used an interhemispheric approach. All torcular dAVFs used the suboccipital, lateral supracerebellar infratentorial approach, with 10.5% undergoing simultaneous ERS craniotomy. Angiographic occlusion rates after microsurgery were 85.5%, 100%, 75.8%, 79.2%, and 73.7% for tentorial, ACF, TSS, convexity/SSS, and torcular dAVFs, respectively ( P = .02); the permanent neurological complication rates were 1.8%, 2.6%, 9.1%, 0%, and 0% ( P = .31). There were no statistically significant differences in development of complications ( P = .08) or Modified Rankin Scale at the last follow-up ( P = .11) by fistula location. CONCLUSION: Although endovascular embolization is the first-line treatment for most intracranial dAVFs, surgical ligation is an important alternative. ACF and tentorial fistulas particularly demonstrate high rates of postoperative obliteration.
Infections in decompensated cirrhosis: Pathophysiology, management, and research agenda
Ferguson, J , Solà, Elsa , Pérez, María Alejandra , Piano, Salvatore , Cheng, Alice G. , Subramanian, Aruna , Kim, W. Ray , Cheng, Alice , Subramanian, Aruna K , Piano, Salvatore , Toll, Jessica Ferguson , Perez, Maria Alejandra

Mayo Clinic

Hepatology Communications | October 4, 2024 | Volume: 8 | Issue: 10 | Pages: No page available

10.1097/hc9.0000000000000539 | PMID 39365139 Get It

Bacterial infections in patients with cirrhosis lead to a 4-fold increase in mortality. Immune dysfunction in cirrhosis further increases the risk of bacterial infections, in addition to alterations in the gut microbiome, which increase the risk of pathogenic bacteria. High rates of empiric antibiotic use contribute to increased incidence of multidrug-resistant organisms and further increases in mortality. Despite continous advances in the field, major unknowns regarding interactions between the immune system and the gut microbiome and strategies to reduce infection risk and improve mortality deserve further investigation. Here, we highlight the unknowns in these major research areas and make a proposal for a research agenda to move toward improving disease progression and outcomes in patients with cirrhosis and infections.
Hypomagnesemia in Large B cell Lymphoma patients receiving CAR T cell therapy correlates with immune dysregulation and decreased PFS: results from the ZUMA-1 trial and Mayo Clinic cohort
Bansal, Radhika , Gandhi, Sangeetha, Babadi, Elham , Martinez, Kodi, McCoy, Gabrielle, Shao, Zuoyi , Regan, Kevin M., Hathcock, Matthew , Wang, Panwen , Ruan, Gordon, Ansell, Stephen M., Johnston, Patrick B., Khurana, Arushi , Hampel, Paul J. , Moreno, Eider, Kharfan‐Dabaja, Mohamed A. , Kim, Jenny , Shen, Rhine R. , Mattie, Mike , Lin, Yi , Witzig, Thomas E., Gile, Jennifer , Mondello, Patrizia , Wang, Zixing , Li, Ying , Zhang, Henan , Wang, Junwen , Saleh, Abdullah S. Al , Ansell, Stephen M. , Bennani, N. Nora , Johnston, Patrick B. , Paludo, Jonas , Villasboas, José C. , Durani, Urshila , Wang, Yucai , Rosenthal, Allison , Muñoz, Javier , Castro, Januario E. , Murthy, Hemant S. , Kenderian, Saad S.

Mayo Clinic

No container title available | October 2, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-4889200/v1 Get It

Abstract Background Hypomagnesemia has been correlated with inferior outcomes in patients with large B cell lymphoma (LBCL) undergoing stem cell transplants. As T-cell and myeloid cell dysfunction have been associated with low magnesium conditions, we investigated whether serum magnesium (Mg) levels could predict clinical outcomes in LBCL patients who received chimeric antigen receptor T-cell therapy. Methods Patients with LBCL who received axi-cel under the ZUMA-1 trial or as FDA approved therapy at Mayo Clinic were examined. Serum samples were obtained at specified time points and cytokine analysis was performed. Single cell RNA sequencing was performed on peripheral blood mononuclear cells. The Student T-test, Kruskal Wallis, or Fisher's Exact Tests were used to compare differences in demographics across Mg levels. Survival curves were plotted using the Kaplan-Meier methodology and compared using the Wilcoxon test. Results We found that hypomagnesemia before lymphodepletion chemotherapy predicted for inferior progression-free and overall survival in the pivotal study ZUMA-1 (NCT02348216). These results were validated in an independent cohort of LBCL patients receiving axicabtagene ciloleucel (axi-cel) at Mayo Clinic. Hypomagnesemia correlated with increased inflammatory serum markers and cytokine levels including ferritin, IL-6, IL1Ra, IL-8, and MIP1a. scRNAseq analysis unveiled altered immune interactions between monocytes and T cells with a concordant immune suppressive transcriptome. Conclusions Hypomagnesemia at the time of CAR-T infusion associates with an unfavorable inflammatory profile and decreased response and survival in LBCL patients receiving axi-cel. These findings suggest a potentially actionable prognostic factor for patients with large cell lymphoma undergoing CAR-T.
Endovascular Ablation of the Greater Splanchnic Nerve in Heart Failure With Preserved Ejection Fraction
Fudim, Marat , Mohan, Rajeev , Price, Matthew J. , Fail, Peter , Hummel, Scott L. , Zirakashvili, Teona, Shaburishvili, Tamaz, Nielsen, Christopher D., Chetcuti, Stanley, Sukul, Devraj , Gulati, Rajiv, Kim, Luke , Benzuly, Keith, Mitter, Sumeet S. , Klein, Liviu , Uriel, Nir , Augostini, Ralph , Blair, John E. , Rocha‐Singh, Krishna J. , Patel, Manesh R. , Somo, Sami I., Hummel, Scott L , Borlaug, Barry A. , Goyal, Parag , Patel, Ravi B. , Reddy, Vivek Y. , Gulati, Rajiv , Burkhoff, Daniel , Litwin, Sheldon E. , Shah, Sanjiv J

Mayo Clinic

JAMA Cardiology | October 2, 2024 | Volume: 9 | Issue: 12 | Pages: 1143

10.1001/jamacardio.2024.2612 | PMID 39356530 Get It

ImportanceGreater splanchnic nerve ablation may improve hemodynamics in patients with heart failure and preserved ejection fraction (HFpEF).ObjectiveTo explore the feasibility and safety of endovascular right-sided splanchnic nerve ablation for volume management (SAVM).Design, Setting, and ParticipantsThis was a phase 2, double-blind, 1:1, sham-controlled, multicenter, randomized clinical trial conducted at 14 centers in the US and 1 center in the Republic of Georgia. Patients with HFpEF, left ventricular ejection fraction of 40% or greater, and invasively measured peak exercise pulmonary capillary wedge pressure (PCWP) of 25 mm Hg or greater were included. Study data were analyzed from May 2023 to June 2024.InterventionSAVM vs sham control procedure.Main Outcomes and MeasuresThe primary efficacy end point was a reduction in legs-up and exercise PCWP at 1 month. The primary safety end point was serious device- or procedure-related adverse events at 1 month. Secondary efficacy end points included HF hospitalizations, changes in exercise function and health status through 12 months, and baseline to 1-month change in resting, legs-up, and 20-W exercise PCWP.ResultsA total of 90 patients (median [range] age, 71 [47-90] years; 58 female [64.4%]) were randomized at 15 centers (44 SAVM vs 46 sham). There were no differences in adverse events between groups. The primary efficacy end point did not differ between SAVM or sham (mean between-group difference in PCWP, −0.03 mm Hg; 95% CI, −2.5 to 2.5 mm Hg; P = .95). There were also no differences in the secondary efficacy end points. There was no difference in the primary safety end point between the treatment (6.8% [3 of 44]) and sham (2.2% [1 of 46]) groups (difference, 4.6%; 95% CI, −6.1% to 15.4%; P = .36). There was no difference in the incidence of orthostatic hypotension between the treatment (11.4% [5 of 44]) and sham (6.5% [3 of 46]) groups (difference, 4.9%; 95% CI, −9.2% to 18.8%; P = .48).Conclusions and RelevanceResults show that SAVM was safe and technically feasible, but it did not reduce exercise PCWP at 1 month or improve clinical outcomes at 12 months in a broad population of patients with HFpEF.Trial RegistrationClinicalTrials.gov Identifier: NCT04592445
Asian Pacific Society of Cardiology Consensus Statements on the Use of Percutaneous Coronary Intervention on Stenosis of the Left Main Coronary Artery
Tan, Jack Wei Chieh , Tan, Huay Cheem , Lee, Michael , Seth, Ashok , Sin, Kenny YK, Firman, Doni , Yap, Jonathan , Sison, Eric Oliver D, Yahya, Achmad Fauzi , Chan, Kok Meng, Chan, Howard Ho Yan, Murasato, Yoshinobu , Malik, Fazila‐Tun‐Nesa , Nguyen, Michael C., Zhang, Bin , Kim, Hyo-Soo , Nguyen, Quang Ngoc , Ako, Junya , Bhindi, Ravinay, Zhang, Junjie , Tam, Frankie Chor-Cheung, Sengottuvelu, G., Ramaiah, Asri Ranga Bin Abdullah, Ali, Rosli Bin Mohd, Harding, S. , Wong, Aaron Sung Lung , Loh, Poay Huan , Hsieh, I-Chang , Kehasukcharoen, Wirash , Linh, Dinh Huynh, Henry, Timothy D. , Tan, Jack Wei Chieh , Lo, Sidney, Sin, Kenny Yoong Kong , Park, Duk‐Woo , Chan, Kok Meng John, Chan, Ho Yan Howard, Nguyen, Michael C, Lee, Kwan , Santoso, Teguh Iman , Wongpraparut, Nattawut , Ramaiah, Asri Ranga Abdullah, Yeo, Khung Keong , Stankovic, Goran R.

Mayo Clinic

Journal of Asian Pacific Society of Cardiology | October 2, 2024 | Volume: 3 | Issue: No issue available | Pages: No page available

10.15420/japsc.2024.27 Get It

Stenosis of the left main coronary artery (LM stenosis) is associated with significant mortality and morbidity due to the large area of affected myocardium. Evidence on the use of percutaneous coronary intervention (PCI) for the treatment of LM stenosis is growing. However, the role of Western guidelines on patients in the Asian-Pacific region is unclear due to anatomical variations, substantial heterogeneity in healthcare resources and infrastructure, and the lack of consensus on the optimal management of LM stenosis in the Asia-Pacific region. Hence, an Asian Pacific Society of Cardiology (APSC) working group developed consensus recommendations on the use of PCI in the management of LM stenosis in the Asia-Pacific region. The APSC expert panel reviewed and appraised the available evidence using the Grading of Recommendations Assessment, Development, and Evaluation system. Consensus recommendations were developed and put to an online vote. Consensus was reached when 80% of votes for a given recommendation were in support of ‘agree’ or ‘neutral’. The resulting 12 statements provide guidance for clinical practitioners in the region on the use of PCI in the treatment of patients with LM stenosis.